Subo, Joji R.

HRN: 15-22-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
CEFUROXIME 1.5GM (VIAL)
08/06/2022
08/07/2022
IV
1.5 Gms X 3 Doses
Q8 X 3 Doses
LTCS
Waiting Final Action 
08/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2022
08/14/2022
IV
500 Mg
Q 8 HRS
TMSAF
Waiting Final Action 
08/07/2022
CEFUROXIME 500MG (TAB)
08/07/2022
08/11/2022
ORAL
1cap
Bid
Prophylaxis For LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: